India · Delayed Price · Currency is INR GPT Healthcare Statistics
Total Valuation
GPT Healthcare has a market cap or net worth of INR 12.36 billion. The enterprise value is 12.80 billion.
| Market Cap | 12.36B |
| Enterprise Value | 12.80B |
Important Dates
The last earnings date was Monday, August 3, 2026.
| Earnings Date | Aug 3, 2026 |
| Ex-Dividend Date | Jul 30, 2026 |
Share Statistics
GPT Healthcare has 82.05 million shares outstanding. The number of shares has increased by 0.32% in one year.
| Current Share Class | 82.05M |
| Shares Outstanding | 82.05M |
| Shares Change (YoY) | +0.32% |
| Shares Change (QoQ) | +0.37% |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 14.66% |
| Float | 26.93M |
Valuation Ratios
The trailing PE ratio is 26.18 and the forward PE ratio is 19.56.
| PE Ratio | 26.18 |
| Forward PE | 19.56 |
| PS Ratio | 2.51 |
| PB Ratio | 4.59 |
| P/TBV Ratio | 4.60 |
| P/FCF Ratio | 31.42 |
| P/OCF Ratio | 15.23 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.92, with an EV/FCF ratio of 32.54.
| EV / Earnings | 27.08 |
| EV / Sales | 2.60 |
| EV / EBITDA | 13.92 |
| EV / EBIT | 19.85 |
| EV / FCF | 32.54 |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.34 |
| Debt / EBITDA | 0.99 |
| Debt / FCF | 2.32 |
| Interest Coverage | 7.99 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 15.98% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 6.12% |
| Revenue Per Employee | 2.31M |
| Profits Per Employee | 222,552 |
| Employee Count | 2,124 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, GPT Healthcare has paid 135.87 million in taxes.
| Income Tax | 135.87M |
| Effective Tax Rate | 22.33% |
Stock Price Statistics
The stock price has decreased by -5.12% in the last 52 weeks. The beta is 0.33, so GPT Healthcare's price volatility has been lower than the market average.
| Beta (5Y) | 0.33 |
| 52-Week Price Change | -5.12% |
| 50-Day Moving Average | 155.25 |
| 200-Day Moving Average | 140.55 |
| Relative Strength Index (RSI) | 40.03 |
| Average Volume (20 Days) | 232,009 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, GPT Healthcare had revenue of INR 4.92 billion and earned 472.70 million in profits. Earnings per share was 5.75.
| Revenue | 4.92B |
| Gross Profit | 2.94B |
| Operating Income | 644.95M |
| Pretax Income | 608.57M |
| Net Income | 472.70M |
| EBITDA | 820.42M |
| EBIT | 644.95M |
| Earnings Per Share (EPS) | 5.75 |
Balance Sheet
The company has 471.96 million in cash and 911.80 million in debt, with a net cash position of -439.84 million or -5.36 per share.
| Cash & Cash Equivalents | 471.96M |
| Total Debt | 911.80M |
| Net Cash | -439.84M |
| Net Cash Per Share | -5.36 |
| Equity (Book Value) | 2.69B |
| Book Value Per Share | 32.84 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was 811.61 million and capital expenditures -418.19 million, giving a free cash flow of 393.42 million.
| Operating Cash Flow | 811.61M |
| Capital Expenditures | -418.19M |
| Depreciation & Amortization | 175.47M |
| Net Borrowing | -88.94M |
| Free Cash Flow | 393.42M |
| FCF Per Share | 4.79 |
Margins
Gross margin is 59.80%, with operating and profit margins of 13.12% and 9.61%.
| Gross Margin | 59.80% |
| Operating Margin | 13.12% |
| Pretax Margin | 12.38% |
| Profit Margin | 9.61% |
| EBITDA Margin | 16.69% |
| EBIT Margin | 13.12% |
| FCF Margin | 8.33% |
Dividends & Yields
This stock pays an annual dividend of 2.50, which amounts to a dividend yield of 1.62%.
| Dividend Per Share | 2.50 |
| Dividend Yield | 1.62% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.32% |
| Shareholder Yield | 1.30% |
| Earnings Yield | 3.82% |
| FCF Yield | 3.18% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |